131 related articles for article (PubMed ID: 32794077)
21. Subcutaneous administration of nimodipine improves bioavailability in rabbits.
Laslo AM; Eastwood JD; Urquhart B; Lee TY; Freeman D
J Neurosci Methods; 2004 Oct; 139(2):195-201. PubMed ID: 15488232
[TBL] [Abstract][Full Text] [Related]
22. Development of two step liquid-liquid extraction tandem UHPLC-MS/MS method for the simultaneous determination of Ginkgo flavonoids, terpene lactones and nimodipine in rat plasma: Application to the pharmacokinetic study of the combination of Ginkgo biloba dispersible tablets and Nimodipine tablets.
Xiao J; Wang T; Li P; Liu R; Li Q; Bi K
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():33-41. PubMed ID: 27318642
[TBL] [Abstract][Full Text] [Related]
23. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies.
Fu Q; Sun J; Zhang D; Li M; Wang Y; Ling G; Liu X; Sun Y; Sui X; Luo C; Sun L; Han X; Lian H; Zhu M; Wang S; He Z
Colloids Surf B Biointerfaces; 2013 Sep; 109():161-6. PubMed ID: 23668980
[TBL] [Abstract][Full Text] [Related]
24. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain.
Zhang Q; Jiang X; Jiang W; Lu W; Su L; Shi Z
Int J Pharm; 2004 May; 275(1-2):85-96. PubMed ID: 15081140
[TBL] [Abstract][Full Text] [Related]
25. Different effect of erythromycin on absorption kinetics of nimodipine in male and female rats.
Liu XD; Wang XL; Xie L; Wang GJ
Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):69-73. PubMed ID: 16010864
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats.
Han KS; Kim YG; Yoo JK; Lee JW; Lee MG
Biopharm Drug Dispos; 1998 Nov; 19(8):493-500. PubMed ID: 9840211
[TBL] [Abstract][Full Text] [Related]
27. Studies on the transdermal delivery of nimodipine from a menthol-based TTS in human volunteers.
Krishnaiah YS; Bhaskar P
Curr Drug Deliv; 2004 Apr; 1(2):93-102. PubMed ID: 16305374
[TBL] [Abstract][Full Text] [Related]
28. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.
Sun Y; Rui Y; Wenliang Z; Tang X
Int J Pharm; 2008 Jul; 359(1-2):144-9. PubMed ID: 18499371
[TBL] [Abstract][Full Text] [Related]
29. Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats.
Aravagiri M; Marder SR
Psychopharmacology (Berl); 2002 Feb; 159(4):424-31. PubMed ID: 11823895
[TBL] [Abstract][Full Text] [Related]
30. Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice.
Abou El Hassan MA; Kedde MA; Zwiers UT; Tourn E; Haenen GR; Bast A; van der Vijgh WJ
Cancer Chemother Pharmacol; 2003 Nov; 52(5):371-6. PubMed ID: 12898182
[TBL] [Abstract][Full Text] [Related]
31. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Lee MH; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous assessment of the intravenous and oral disposition of the enantiomers of racemic nimodipine by chiral stationary-phase high-performance liquid chromatography and gas chromatography/mass spectroscopy combined with a stable isotope technique.
Fischer C; Schönberger F; Mück W; Heuck K; Eichelbaum M
J Pharm Sci; 1993 Mar; 82(3):244-50. PubMed ID: 8450415
[TBL] [Abstract][Full Text] [Related]
33. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
[TBL] [Abstract][Full Text] [Related]
34. Determination of a novel carbamate AChE inhibitor meserine in mouse plasma, brain and rat plasma by LC-MS/MS: application to pharmacokinetic study after intravenous and subcutaneous administration.
Xie Y; Jiang P; Ge X; Wang H; Shao B; Xie Q; Qiu Z; Chen H
J Pharm Biomed Anal; 2014 Aug; 96():156-61. PubMed ID: 24747147
[TBL] [Abstract][Full Text] [Related]
35. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model.
Marchettini P; Stuart OA; Mohamed F; Yoo D; Sugarbaker PH
Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and plasma concentrations of acetylsalicylic acid after intravenous, rectal, and intragastric administration to horses.
Broome TA; Brown MP; Gronwall RR; Casey MF; Meritt KA
Can J Vet Res; 2003 Oct; 67(4):297-302. PubMed ID: 14620867
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
[TBL] [Abstract][Full Text] [Related]
38. P-glycoprotein restricted transport of nimodipine across blood-brain barrier.
Zhang L; Liu XD; Xie L; Wang GJ
Acta Pharmacol Sin; 2003 Sep; 24(9):903-6. PubMed ID: 12956939
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in rats.
Bhattaram VA; Paliwal JK; Gupta RC
Biopharm Drug Dispos; 2004 Mar; 25(2):69-75. PubMed ID: 14872554
[TBL] [Abstract][Full Text] [Related]
40. Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing.
Tan AY; LeVatte TL; Archibald ML; Tremblay F; Kelly ME; Chauhan BC
J Glaucoma; 2002 Apr; 11(2):134-42. PubMed ID: 11912361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
